The overall goal of the TGen study was to look at genomic and
epigenomic events to understand the causes of breast cancer brain metastatic lesions, and identify potential new therapeutic targets.
The SEMM organizes international
events for the promotion of research and dissemination of results in relatively broad scientific areas such as Molecular Oncology, Molecular Medicine,
Epigenomics, and Biomedical Humanities.